Clinical Trial Update: Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the short-term efficacy of Triamcinolone Acetonide (Aristocort C) in subjects with atopic dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Aristocort C (Triamcinolone Acetonide)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED